Results 61 to 70 of about 10,443 (200)
Phenotypic Expansion of Knobloch Syndrome Type 2 in an Individual With a De Novo PAK2 Variant
American Journal of Medical Genetics Part A, Volume 197, Issue 6, June 2025.ABSTRACT P21‐activated kinase 2 (PAK2) is a serine/threonine kinase essential for a variety of cellular processes including signal transduction, cellular survival, proliferation, and migration. A recent report proposed monoallelic PAK2 variants cause Knobloch syndrome type 2 (KNO2)—a developmental disorder primarily characterized by ocular anomalies ...
Elizabeth A. Werren +10 more
wiley +1 more source
Aceite de silicona para el tratamiento de la maculopatía hipotónica [PDF]
, 2005 Case report: We report a case of a man who developed hypotonic maculopathy after vitreoretinal surgery for anterior proliferative vitreoretinopathy.
Fernandez-Hortelano, A. (A.) +4 more
core +1 more source
The effect of axial length on pseudophakic retinal detachment
Acta Ophthalmologica, Volume 103, Issue 2, Page 146-151, March 2025.Abstract Purpose The purpose of the study was to analyse the surgical management and outcome regarding axial length in the population affected by pseudophakic retinal detachment (PRD) 2015–2020. Method The patients included were from an observational cohort study of patients undergoing cataract surgery in the region of Skåne during 2015–2017. Data were
Joakim Thylefors +2 more
wiley +1 more source
The impact of octreotide in experimental proliferative vitreoretinopathy
Indian Journal of Ophthalmology, 2013 Aims: This study aims to investigate the effects of intravitreal octreotide on the growth factors, which have significant roles in the pathogenesis of proliferative vitreoretinopathy (PVR). Settings and Design: An experimental trial.
Ozge Evren +3 more
doaj +1 more source
Osteoprotegerin is a new regulator of inflammation and angiogenesis in proliferative diabetic retinopathy [PDF]
, 2003 Osteoprotegerin (OPG) is a novel regulator of endothelial cell function, angiogenesis, and vasculogenesis. We correlated expression levels of OPG with those of the angiogenic and inflammatory factors vascular endothelial growth factor (VEGF) and monocyte
Abu El-Asrar, Ahmed M +11 more
core +3 more sources
Levodopa‐Responsive Dystonia Secondary to CTNNB1 Neurodevelopmental Disorder
Movement Disorders Clinical Practice, EarlyView.
Hanin Algethami +5 more
wiley +1 more source
Acta Ophthalmologica, Volume 103, Issue 2, Page 152-161, March 2025.Abstract Purpose To report clinical and genetic characteristics of familial exudative vitreoretinopathy (FEVR) in the Finnish population. Methods Detailed clinical and genetic data of 35 individuals with heterozygous pathogenic variants in FZD4 were gathered and analysed.
Laura Lähteenoja +6 more
wiley +1 more source
Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model.
PLoS ONE, 2020 Proliferative vitreoretinopathy (PVR) is a progressive disease that develops in a subset of patients who undergo surgery for retinal detachment repair, and results in significant vision loss.
Alison M Heffer +5 more
doaj +1 more source
Therapeutic Interventions against Inflammatory and Angiogenic Mediators in Proliferative Diabetic Retinopathy [PDF]
, 2012 The global prevalence of diabetes is estimated to be 336 million people, with diabetic complications contributing to significant worldwide morbidity and mortality.
Gologorsky, Daniel +2 more
core +3 more sources
IJRETINA (International Journal of Retina), 2019 Introduction: The aim of this study is to evaluate the incidence and characteristics of retinal detachment patients with proliferative vitreoretinopathy.
Ifan Romadhon Lukmana +7 more
doaj +1 more source